Cargando…

Amniotic fluid embolism as a cause of maternal mortality in China between 1996 and 2013: a population-based retrospective study

BACKGROUND: To analyse the maternal mortality ratio, demographic and pregnancy related details in women who suffered a fatal amniotic fluid embolism (AFE) in China. METHODS: A retrospective population based study using data collected as part of the National Maternal Mortality Surveillance System bet...

Descripción completa

Detalles Bibliográficos
Autores principales: Mu, Yi, McDonnell, Nolan, Li, Zhuoyang, Liang, Juan, Wang, Yanping, Zhu, Jun, Sullivan, Elizabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069862/
https://www.ncbi.nlm.nih.gov/pubmed/27760522
http://dx.doi.org/10.1186/s12884-016-1106-6
_version_ 1782461020576415744
author Mu, Yi
McDonnell, Nolan
Li, Zhuoyang
Liang, Juan
Wang, Yanping
Zhu, Jun
Sullivan, Elizabeth
author_facet Mu, Yi
McDonnell, Nolan
Li, Zhuoyang
Liang, Juan
Wang, Yanping
Zhu, Jun
Sullivan, Elizabeth
author_sort Mu, Yi
collection PubMed
description BACKGROUND: To analyse the maternal mortality ratio, demographic and pregnancy related details in women who suffered a fatal amniotic fluid embolism (AFE) in China. METHODS: A retrospective population based study using data collected as part of the National Maternal Mortality Surveillance System between 1996 and 2013. Data were collected onto a standardised form from women whose cause of death was listed as being secondary to AFE. RESULTS: Records were available for 640 deaths. Over the 17 year period the maternal mortality ratio for AFE decreased from 4.4 per 100,000 births (95 % confidence interval (CI):2.72–6.12) to 1.9 per 100,000 births (95 % CI:1.35–2.54). Over the same period the proportion of maternal deaths secondary to AFE increased from 6.8 to 12.5 %. The mean age of women who died was 30.1 years and the onset of the AFE occurred prior to delivery in 39 %. The most prominent presenting features included premonitory symptoms (29 %), acute fetal compromise (28 %), maternal haemorrhage (16 %) and shortness of breath (15 %). CONCLUSIONS: Maternal mortality secondary to AFE has decreased in China, however at a slower rate than mortality secondary to other conditions. Active surveillance is recommended to assess case fatality rates, risk factors and other lessons specific to this population.
format Online
Article
Text
id pubmed-5069862
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-50698622016-10-24 Amniotic fluid embolism as a cause of maternal mortality in China between 1996 and 2013: a population-based retrospective study Mu, Yi McDonnell, Nolan Li, Zhuoyang Liang, Juan Wang, Yanping Zhu, Jun Sullivan, Elizabeth BMC Pregnancy Childbirth Research Article BACKGROUND: To analyse the maternal mortality ratio, demographic and pregnancy related details in women who suffered a fatal amniotic fluid embolism (AFE) in China. METHODS: A retrospective population based study using data collected as part of the National Maternal Mortality Surveillance System between 1996 and 2013. Data were collected onto a standardised form from women whose cause of death was listed as being secondary to AFE. RESULTS: Records were available for 640 deaths. Over the 17 year period the maternal mortality ratio for AFE decreased from 4.4 per 100,000 births (95 % confidence interval (CI):2.72–6.12) to 1.9 per 100,000 births (95 % CI:1.35–2.54). Over the same period the proportion of maternal deaths secondary to AFE increased from 6.8 to 12.5 %. The mean age of women who died was 30.1 years and the onset of the AFE occurred prior to delivery in 39 %. The most prominent presenting features included premonitory symptoms (29 %), acute fetal compromise (28 %), maternal haemorrhage (16 %) and shortness of breath (15 %). CONCLUSIONS: Maternal mortality secondary to AFE has decreased in China, however at a slower rate than mortality secondary to other conditions. Active surveillance is recommended to assess case fatality rates, risk factors and other lessons specific to this population. BioMed Central 2016-10-19 /pmc/articles/PMC5069862/ /pubmed/27760522 http://dx.doi.org/10.1186/s12884-016-1106-6 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Mu, Yi
McDonnell, Nolan
Li, Zhuoyang
Liang, Juan
Wang, Yanping
Zhu, Jun
Sullivan, Elizabeth
Amniotic fluid embolism as a cause of maternal mortality in China between 1996 and 2013: a population-based retrospective study
title Amniotic fluid embolism as a cause of maternal mortality in China between 1996 and 2013: a population-based retrospective study
title_full Amniotic fluid embolism as a cause of maternal mortality in China between 1996 and 2013: a population-based retrospective study
title_fullStr Amniotic fluid embolism as a cause of maternal mortality in China between 1996 and 2013: a population-based retrospective study
title_full_unstemmed Amniotic fluid embolism as a cause of maternal mortality in China between 1996 and 2013: a population-based retrospective study
title_short Amniotic fluid embolism as a cause of maternal mortality in China between 1996 and 2013: a population-based retrospective study
title_sort amniotic fluid embolism as a cause of maternal mortality in china between 1996 and 2013: a population-based retrospective study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069862/
https://www.ncbi.nlm.nih.gov/pubmed/27760522
http://dx.doi.org/10.1186/s12884-016-1106-6
work_keys_str_mv AT muyi amnioticfluidembolismasacauseofmaternalmortalityinchinabetween1996and2013apopulationbasedretrospectivestudy
AT mcdonnellnolan amnioticfluidembolismasacauseofmaternalmortalityinchinabetween1996and2013apopulationbasedretrospectivestudy
AT lizhuoyang amnioticfluidembolismasacauseofmaternalmortalityinchinabetween1996and2013apopulationbasedretrospectivestudy
AT liangjuan amnioticfluidembolismasacauseofmaternalmortalityinchinabetween1996and2013apopulationbasedretrospectivestudy
AT wangyanping amnioticfluidembolismasacauseofmaternalmortalityinchinabetween1996and2013apopulationbasedretrospectivestudy
AT zhujun amnioticfluidembolismasacauseofmaternalmortalityinchinabetween1996and2013apopulationbasedretrospectivestudy
AT sullivanelizabeth amnioticfluidembolismasacauseofmaternalmortalityinchinabetween1996and2013apopulationbasedretrospectivestudy